Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains-Reference-Cited by-同舟云学术

Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains

Published:2013-11-06 Issue:2 Volume:88 Page:1125-1139
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Chen W.,Feng Y.,Prabakaran P.,Ying T.,Wang Y.,Sun J.,Macedo C. D. S.,Zhu Z.,He Y.,Polonis V. R.,Dimitrov D. S.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference71 articles.

1. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells;Dimitrov;Virology,1992

2. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen;Smith;Science,1987

3. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex: a phase 1 study;Kahn;Ann. Intern. Med.,1990

4. Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection;Schacker;J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.,1995

5. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex: a phase I-II escalating dosage trial;Schooley;Ann. Intern. Med.,1990

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control;Metabolic Engineering;2024-09

2. Reprogramming human B cells with custom heavy-chain antibodies;Nature Biomedical Engineering;2024-07-22

3. Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study;Cell Discovery;2024-05-14

4. Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation;Current Research in Microbial Sciences;2024

5. Scalable, Robust, High-throughput Expression, Purification & Characterization of Nanobodies Enabled by 2-Stage Dynamic Control;2023-12-14